21339-55-9,MFCD00467133
Catalog No.:AA0032E0

21339-55-9 | (S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$35.00   $24.00
- +
250mg
95%
in stock  
$56.00   $39.00
- +
1g
96%
in stock  
$62.00   $44.00
- +
5g
96%
in stock  
$150.00   $105.00
- +
25g
96%
in stock  
$697.00 $488.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0032E0
Chemical Name:
(S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid
CAS Number:
21339-55-9
Molecular Formula:
C12H14N2O2
Molecular Weight:
218.2518
MDL Number:
MFCD00467133
SMILES:
OC(=O)[C@H](Cc1cn(c2c1cccc2)C)N
Properties
Properties
 
BP:
429.3°C/760mmHg  
Form:
Solid  
MP:
242-245°C(lit.);  
Storage:
2-8℃;  

Computed Properties
 
Complexity:
270  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-1.3  

Literature

Title: Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice.

Journal: Arthritis and rheumatism 20120701

Title: Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi.

Journal: PLoS neglected tropical diseases 20120701

Title: Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats.

Journal: Cell biochemistry and function 20120601

Title: Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.

Journal: Kidney international 20120501

Title: Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.

Journal: Cancer science 20120501

Title: L-tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20120415

Title: Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.

Journal: Bioorganic & medicinal chemistry 20120201

Title: Novel Cβ-Cγ bond cleavages of tryptophan-containing peptide radical cations.

Journal: Journal of the American Society for Mass Spectrometry 20120201

Title: Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection.

Journal: The Journal of infectious diseases 20120101

Title: The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression.

Journal: Journal of Alzheimer's disease : JAD 20120101

Title: IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20120101

Title: The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection.

Journal: Journal of biomedical science 20120101

Title: Modulation of tumor tolerance in primary central nervous system malignancies.

Journal: Clinical & developmental immunology 20120101

Title: Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.

Journal: PloS one 20120101

Title: Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.

Journal: Clinical & developmental immunology 20120101

Title: Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.

Journal: Frontiers in immunology 20120101

Title: The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes.

Journal: Immunological investigations 20120101

Title: On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation.

Journal: Frontiers in immunology 20120101

Title: The antioxidant role of xanthurenic acid in the Aedes aegypti midgut during digestion of a blood meal.

Journal: PloS one 20120101

Title: Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.

Journal: PloS one 20120101

Title: The mechanism of formation of N-formylkynurenine by heme dioxygenases.

Journal: Journal of the American Chemical Society 20111012

Title: SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.

Journal: The Journal of biological chemistry 20110909

Title: Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.

Journal: Nature medicine 20110901

Title: The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

Journal: Clinical and experimental immunology 20110801

Title: Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

Journal: European journal of medicinal chemistry 20110701

Title: Contribution of dehydroepiandrosterone sulfate and progesterone to in vitro regulation of tolerogenic activity of IFN-α-induced dendritic cells.

Journal: Bulletin of experimental biology and medicine 20110601

Title: Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20110501

Title: Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to Trichuris muris infection.

Journal: Parasite immunology 20110401

Title: Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

Journal: Cancer research 20110315

Title: Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.

Journal: Medical oncology (Northwood, London, England) 20110301

Title: Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

Journal: Bioorganic & medicinal chemistry 20110215

Title: Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).

Journal: PloS one 20110101

Title: Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

Journal: PloS one 20110101

Title: The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.

Journal: PloS one 20110101

Title: An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function.

Journal: PloS one 20110101

Title: Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation.

Journal: Journal of neuroinflammation 20110101

Title: Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.

Journal: PloS one 20110101

Title: Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.

Journal: Clinical & developmental immunology 20110101

Title: Tryptophan transport in human fibroblast cells-a functional characterization.

Journal: International journal of tryptophan research : IJTR 20110101

Title: Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.

Journal: International journal of tryptophan research : IJTR 20110101

Title: Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.

Journal: Clinical & developmental immunology 20110101

Title: Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide.

Journal: PloS one 20110101

Title: Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

Title: Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression.

Journal: Transplantation 20101227

Title: Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.

Journal: Haematologica 20101201

Title: Pancreatic islet transplants and IDO: when starving the enemy does you good.

Journal: Diabetes 20100901

Title: A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Journal: Experimental biology and medicine (Maywood, N.J.) 20100701

Title: Rational design of indoleamine 2,3-dioxygenase inhibitors.

Journal: Journal of medicinal chemistry 20100211

Title: Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.

Journal: World journal of gastroenterology 20100207

Title: DC expressing transgene Foxp3 are regulatory APC.

Journal: European journal of immunology 20100201

Title: The role of indoleamine 2,3-dioxygenase in retinal pigment epithelial cell-mediated immune modulation.

Journal: Ocular immunology and inflammation 20100101

Title: Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.

Journal: Immunology and cell biology 20100101

Title: Therapeutic cancer vaccines in combination with conventional therapy.

Journal: Journal of biomedicine & biotechnology 20100101

Title: Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.

Journal: Immunobiology 20100101

Title: Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.

Journal: PloS one 20100101

Title: Indoleamine 2,3-dioxygenase: is it an immune suppressor?

Journal: Cancer journal (Sudbury, Mass.) 20100101

Title: Trends in cancer immunotherapy.

Journal: Clinical Medicine Insights. Oncology 20100101

Title: IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease.

Journal: International journal of tryptophan research : IJTR 20100101

Title: Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

Journal: International journal of tryptophan research : IJTR 20100101

Title: Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.

Journal: Gynecologic oncology 20091101

Title: IDO and outcomes in ovarian cancer.

Journal: Gynecologic oncology 20091101

Title: Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.

Journal: Journal of the American Chemical Society 20090916

Title: Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.

Journal: Cancer research 20090701

Title: IDO inhibits T-cell function through suppressing Vav1 expression and activation.

Journal: Cancer biology & therapy 20090701

Title: The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20090615

Title: CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.

Journal: European journal of immunology 20090601

Title: Origins and functional basis of regulatory CD11c+CD8+ T cells.

Journal: European journal of immunology 20090601

Title: Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

Journal: Experimental & molecular medicine 20090531

Title: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

Journal: Molecular psychiatry 20090501

Title: Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.

Journal: Human immunology 20090501

Title: Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates crescentic glomerulonephritis.

Journal: Clinical and experimental immunology 20090501

Title: Prevention of spontaneous tumor development in a ret transgenic mouse model by ret peptide vaccination with indoleamine 2,3-dioxygenase inhibitor 1-methyl tryptophan.

Journal: Cancer research 20090501

Title: Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.

Journal: Journal of the American College of Surgeons 20090501

Title: Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20090401

Title: Tryptophan catabolites regulate mucosal sensitization to ovalbumin in respiratory airways.

Journal: Allergy 20090301

Title: IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

Journal: Cancer immunology, immunotherapy : CII 20090101

Title: Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.

Journal: BMC cancer 20090101

Title: The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.

Journal: Journal of translational medicine 20090101

Title: The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.

Journal: PloS one 20090101

Title: Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.

Journal: BMC cancer 20090101

Title: Kynurenine pathway metabolites in humans: disease and healthy States.

Journal: International journal of tryptophan research : IJTR 20090101

Title: The physiological action of picolinic Acid in the human brain.

Journal: International journal of tryptophan research : IJTR 20090101

Title: Cell cycle arrest by kynurenine in lens epithelial cells.

Journal: Investigative ophthalmology & visual science 20081201

Title: Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.

Journal: Molecular cancer therapeutics 20081201

Title: Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

Journal: Langenbeck's archives of surgery 20081101

Title: The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20081015

Title: Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.

Journal: The Biochemical journal 20080915

Title: Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.

Journal: Bioorganic & medicinal chemistry 20080915

Title: Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

Journal: Journal of medicinal chemistry 20080828

Title: The preference of tryptophan for membrane interfaces: insights from N-methylation of tryptophans in gramicidin channels.

Journal: The Journal of biological chemistry 20080808

Title: [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].

Journal: Klinische Monatsblatter fur Augenheilkunde 20080801

Title: Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.

Journal: Journal of cancer research and clinical oncology 20080501

Title: Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase.

Journal: Immunology letters 20080415

Title: Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.

Journal: FEMS immunology and medical microbiology 20080301

Title: Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

Journal: Blood 20080215

Title: Increased striatal serotonin synthesis following cortical resection in children with intractable epilepsy.

Journal: Epilepsy research 20080201

Title: The role of tryptophan metabolism in iNOS transcription and nitric oxide production by chicken macrophage cells upon treatment with interferon gamma.

Journal: Immunology letters 20080129

Title: Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.

Journal: Cancer research 20080101

Title: Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus.

Journal: PloS one 20080101

Title: Low dose Zebularine treatment enhances immunogenicity of tumor cells.

Journal: Cancer letters 20071108

Title: Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.

Journal: Experimental eye research 20071101

Title: Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.

Journal: Clinical and vaccine immunology : CVI 20071101

Title: Effect of Kidney-replenishing herb on the indoleamine 2,3-dioxygenase of human syncytiotrophoblasts cultured in vitro and the balance of helper T-cell cytokines.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20071101

Title: Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats.

Journal: Transplantation 20071027

Title: Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20071015

Title: Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

Journal: Immunology letters 20070815

Title: Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.

Journal: Clinical and experimental immunology 20070801

Title: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.

Journal: Cancer research 20070801

Title: Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20070715

Title: Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.

Journal: Diabetes 20070601

Title: Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan.

Journal: Zhongguo shi yan xue ye xue za zhi 20070601

Title: HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

Journal: Blood 20070415

Title: Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease.

Journal: Current drug metabolism 20070401

Title: Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Journal: Cancer research 20070115

Title: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

Journal: Blood 20070101

Title: Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.

Journal: Arthritis research & therapy 20070101

Title: Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.

Journal: Immunology letters 20061115

Title: Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.

Journal: Journal of natural products 20061001

Title: 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20060801

Title: Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20060701

Title: 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms.

Journal: Cytokine 20060601

Title: Perinatal immunotoxicity: why adult exposure assessment fails to predict risk.

Journal: Environmental health perspectives 20060401

Title: Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage.

Journal: Experimental eye research 20060301

Title: Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.

Journal: Biotechnology journal 20060301

Title: Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.

Journal: The Journal of infectious diseases 20060115

Title: Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

Journal: European journal of immunology 20060101

Title: Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.

Journal: Immunology 20051101

Title: Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.

Journal: Biology of reproduction 20050901

Title: Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050801

Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.

Journal: Chemical research in toxicology 20050601

Title: Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.

Journal: Cell research 20050301

Title: Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.

Journal: Clinical and experimental immunology 20041101

Title: Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.

Journal: Steroids 20040901

Title: Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.

Journal: Journal of reproductive immunology 20040401

Title: Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells.

Journal: Biochimica et biophysica acta 20040210

Title: Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.

Journal: Human immunology 20040201

Title: Comparative effects of L-tryptophan and 1-methyl-tryptophan on immunoregulation induced by sperm, human pre-implantation embryo and trophoblast supernatants.

Journal: American journal of reproductive immunology (New York, N.Y. : 1989) 20031001

Title: Interferon-gamma independent oxidation of melatonin by macrophages.

Journal: Journal of pineal research 20030101

Title: Tryptophan pyrrole ring cleavage enzymes in placenta.

Journal: Advances in experimental medicine and biology 20030101

Title: Instruction of translating ribosome by nascent peptide.

Journal: Science (New York, N.Y.) 20020913

Title: Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Journal: Science (New York, N.Y.) 20020913

Title: FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20020815

Title: Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.

Journal: Journal of neuroimmunology 20020801

Title: Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.

Journal: The Journal of physiology 20010815

Title: Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles.

Journal: The Journal of physiology 20010301

Title: The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants.

Journal: The Journal of physiology 20010301

Title: Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts.

Journal: Transplantation proceedings 20010101

Title: Huang GL, et, al. PEG-Poly(1-Methyl-l-Tryptophan)-Based Polymeric Micelles as Enzymatically Activated Inhibitors of Indoleamine 2,3-Dioxygenase. Nanomaterials (Basel). 2019 May 9;9(5):719.

Title: Liu X, et, al. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells. Int J Cancer. 2018 Sep 15;143(6):1516-1529.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:21339-55-9 Molecular Formula|21339-55-9 MDL|21339-55-9 SMILES|21339-55-9 (S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid
Catalog No.: AA0032E0
21339-55-9,MFCD00467133
21339-55-9 | (S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid
Pack Size: 100mg
Purity: 95%
in stock
$35.00 $24.00
Pack Size: 250mg
Purity: 95%
in stock
$56.00 $39.00
Pack Size: 1g
Purity: 96%
in stock
$62.00 $44.00
Pack Size: 5g
Purity: 96%
in stock
$150.00 $105.00
Pack Size: 25g
Purity: 96%
in stock
$697.00 $488.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0032E0
Chemical Name: (S)-2-Amino-3-(1-methyl-1h-indol-3-yl)propanoic acid
CAS Number: 21339-55-9
Molecular Formula: C12H14N2O2
Molecular Weight: 218.2518
MDL Number: MFCD00467133
SMILES: OC(=O)[C@H](Cc1cn(c2c1cccc2)C)N
Properties
BP: 429.3°C/760mmHg  
Form: Solid  
MP: 242-245°C(lit.);  
Storage: 2-8℃;  
Complexity: 270  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 16  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -1.3  
Literature fold

Title: Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice.

Journal: Arthritis and rheumatism20120701

Title: Activation of indoleamine 2,3-dioxygenase in patients with scrub typhus and its role in growth restriction of Orientia tsutsugamushi.

Journal: PLoS neglected tropical diseases20120701

Title: Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats.

Journal: Cell biochemistry and function20120601

Title: Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.

Journal: Kidney international20120501

Title: Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.

Journal: Cancer science20120501

Title: L-tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice.

Journal: Journal of immunology (Baltimore, Md. : 1950)20120415

Title: Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.

Journal: Bioorganic & medicinal chemistry20120201

Title: Novel Cβ-Cγ bond cleavages of tryptophan-containing peptide radical cations.

Journal: Journal of the American Society for Mass Spectrometry20120201

Title: Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection.

Journal: The Journal of infectious diseases20120101

Title: The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression.

Journal: Journal of Alzheimer's disease : JAD20120101

Title: IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.

Journal: Journal of immunology (Baltimore, Md. : 1950)20120101

Title: The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection.

Journal: Journal of biomedical science20120101

Title: Modulation of tumor tolerance in primary central nervous system malignancies.

Journal: Clinical & developmental immunology20120101

Title: Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.

Journal: PloS one20120101

Title: Targeting multiple-myeloma-induced immune dysfunction to improve immunotherapy outcomes.

Journal: Clinical & developmental immunology20120101

Title: Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases.

Journal: Frontiers in immunology20120101

Title: The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes.

Journal: Immunological investigations20120101

Title: On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation.

Journal: Frontiers in immunology20120101

Title: The antioxidant role of xanthurenic acid in the Aedes aegypti midgut during digestion of a blood meal.

Journal: PloS one20120101

Title: Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.

Journal: PloS one20120101

Title: The mechanism of formation of N-formylkynurenine by heme dioxygenases.

Journal: Journal of the American Chemical Society20111012

Title: SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.

Journal: The Journal of biological chemistry20110909

Title: Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.

Journal: Nature medicine20110901

Title: The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

Journal: Clinical and experimental immunology20110801

Title: Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

Journal: European journal of medicinal chemistry20110701

Title: Contribution of dehydroepiandrosterone sulfate and progesterone to in vitro regulation of tolerogenic activity of IFN-α-induced dendritic cells.

Journal: Bulletin of experimental biology and medicine20110601

Title: Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.

Journal: Naunyn-Schmiedeberg's archives of pharmacology20110501

Title: Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to Trichuris muris infection.

Journal: Parasite immunology20110401

Title: Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

Journal: Cancer research20110315

Title: Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.

Journal: Medical oncology (Northwood, London, England)20110301

Title: Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.

Journal: Bioorganic & medicinal chemistry20110215

Title: Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).

Journal: PloS one20110101

Title: Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

Journal: PloS one20110101

Title: The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.

Journal: PloS one20110101

Title: An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function.

Journal: PloS one20110101

Title: Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation.

Journal: Journal of neuroinflammation20110101

Title: Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.

Journal: PloS one20110101

Title: Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.

Journal: Clinical & developmental immunology20110101

Title: Tryptophan transport in human fibroblast cells-a functional characterization.

Journal: International journal of tryptophan research : IJTR20110101

Title: Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.

Journal: International journal of tryptophan research : IJTR20110101

Title: Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.

Journal: Clinical & developmental immunology20110101

Title: Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide.

Journal: PloS one20110101

Title: Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences20110101

Title: Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression.

Journal: Transplantation20101227

Title: Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.

Journal: Haematologica20101201

Title: Pancreatic islet transplants and IDO: when starving the enemy does you good.

Journal: Diabetes20100901

Title: A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Journal: Experimental biology and medicine (Maywood, N.J.)20100701

Title: Rational design of indoleamine 2,3-dioxygenase inhibitors.

Journal: Journal of medicinal chemistry20100211

Title: Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.

Journal: World journal of gastroenterology20100207

Title: DC expressing transgene Foxp3 are regulatory APC.

Journal: European journal of immunology20100201

Title: The role of indoleamine 2,3-dioxygenase in retinal pigment epithelial cell-mediated immune modulation.

Journal: Ocular immunology and inflammation20100101

Title: Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO.

Journal: Immunology and cell biology20100101

Title: Therapeutic cancer vaccines in combination with conventional therapy.

Journal: Journal of biomedicine & biotechnology20100101

Title: Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma.

Journal: Immunobiology20100101

Title: Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.

Journal: PloS one20100101

Title: Indoleamine 2,3-dioxygenase: is it an immune suppressor?

Journal: Cancer journal (Sudbury, Mass.)20100101

Title: Trends in cancer immunotherapy.

Journal: Clinical Medicine Insights. Oncology20100101

Title: IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease.

Journal: International journal of tryptophan research : IJTR20100101

Title: Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

Journal: International journal of tryptophan research : IJTR20100101

Title: Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.

Journal: Gynecologic oncology20091101

Title: IDO and outcomes in ovarian cancer.

Journal: Gynecologic oncology20091101

Title: Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.

Journal: Journal of the American Chemical Society20090916

Title: Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.

Journal: Cancer research20090701

Title: IDO inhibits T-cell function through suppressing Vav1 expression and activation.

Journal: Cancer biology & therapy20090701

Title: The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity.

Journal: Journal of immunology (Baltimore, Md. : 1950)20090615

Title: CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.

Journal: European journal of immunology20090601

Title: Origins and functional basis of regulatory CD11c+CD8+ T cells.

Journal: European journal of immunology20090601

Title: Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10.

Journal: Experimental & molecular medicine20090531

Title: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

Journal: Molecular psychiatry20090501

Title: Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.

Journal: Human immunology20090501

Title: Inhibition of indoleamine 2, 3-dioxygenase-mediated tryptophan catabolism accelerates crescentic glomerulonephritis.

Journal: Clinical and experimental immunology20090501

Title: Prevention of spontaneous tumor development in a ret transgenic mouse model by ret peptide vaccination with indoleamine 2,3-dioxygenase inhibitor 1-methyl tryptophan.

Journal: Cancer research20090501

Title: Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.

Journal: Journal of the American College of Surgeons20090501

Title: Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.

Journal: Journal of immunology (Baltimore, Md. : 1950)20090401

Title: Tryptophan catabolites regulate mucosal sensitization to ovalbumin in respiratory airways.

Journal: Allergy20090301

Title: IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

Journal: Cancer immunology, immunotherapy : CII20090101

Title: Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.

Journal: BMC cancer20090101

Title: The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer.

Journal: Journal of translational medicine20090101

Title: The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.

Journal: PloS one20090101

Title: Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.

Journal: BMC cancer20090101

Title: Kynurenine pathway metabolites in humans: disease and healthy States.

Journal: International journal of tryptophan research : IJTR20090101

Title: The physiological action of picolinic Acid in the human brain.

Journal: International journal of tryptophan research : IJTR20090101

Title: Cell cycle arrest by kynurenine in lens epithelial cells.

Journal: Investigative ophthalmology & visual science20081201

Title: Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.

Journal: Molecular cancer therapeutics20081201

Title: Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

Journal: Langenbeck's archives of surgery20081101

Title: The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.

Journal: Journal of immunology (Baltimore, Md. : 1950)20081015

Title: Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.

Journal: The Biochemical journal20080915

Title: Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.

Journal: Bioorganic & medicinal chemistry20080915

Title: Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

Journal: Journal of medicinal chemistry20080828

Title: The preference of tryptophan for membrane interfaces: insights from N-methylation of tryptophans in gramicidin channels.

Journal: The Journal of biological chemistry20080808

Title: [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].

Journal: Klinische Monatsblatter fur Augenheilkunde20080801

Title: Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.

Journal: Journal of cancer research and clinical oncology20080501

Title: Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase.

Journal: Immunology letters20080415

Title: Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.

Journal: FEMS immunology and medical microbiology20080301

Title: Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

Journal: Blood20080215

Title: Increased striatal serotonin synthesis following cortical resection in children with intractable epilepsy.

Journal: Epilepsy research20080201

Title: The role of tryptophan metabolism in iNOS transcription and nitric oxide production by chicken macrophage cells upon treatment with interferon gamma.

Journal: Immunology letters20080129

Title: Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.

Journal: Cancer research20080101

Title: Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus.

Journal: PloS one20080101

Title: Low dose Zebularine treatment enhances immunogenicity of tumor cells.

Journal: Cancer letters20071108

Title: Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.

Journal: Experimental eye research20071101

Title: Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle.

Journal: Clinical and vaccine immunology : CVI20071101

Title: Effect of Kidney-replenishing herb on the indoleamine 2,3-dioxygenase of human syncytiotrophoblasts cultured in vitro and the balance of helper T-cell cytokines.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology20071101

Title: Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats.

Journal: Transplantation20071027

Title: Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege.

Journal: Journal of immunology (Baltimore, Md. : 1950)20071015

Title: Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

Journal: Immunology letters20070815

Title: Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.

Journal: Clinical and experimental immunology20070801

Title: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.

Journal: Cancer research20070801

Title: Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.

Journal: Journal of immunology (Baltimore, Md. : 1950)20070715

Title: Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.

Journal: Diabetes20070601

Title: Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan.

Journal: Zhongguo shi yan xue ye xue za zhi20070601

Title: HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

Journal: Blood20070415

Title: Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease.

Journal: Current drug metabolism20070401

Title: Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Journal: Cancer research20070115

Title: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

Journal: Blood20070101

Title: Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.

Journal: Arthritis research & therapy20070101

Title: Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.

Journal: Immunology letters20061115

Title: Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.

Journal: Journal of natural products20061001

Title: 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.

Journal: Journal of immunology (Baltimore, Md. : 1950)20060801

Title: Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO.

Journal: Journal of immunology (Baltimore, Md. : 1950)20060701

Title: 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms.

Journal: Cytokine20060601

Title: Perinatal immunotoxicity: why adult exposure assessment fails to predict risk.

Journal: Environmental health perspectives20060401

Title: Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage.

Journal: Experimental eye research20060301

Title: Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.

Journal: Biotechnology journal20060301

Title: Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.

Journal: The Journal of infectious diseases20060115

Title: Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

Journal: European journal of immunology20060101

Title: Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.

Journal: Immunology20051101

Title: Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.

Journal: Biology of reproduction20050901

Title: Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation.

Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology20050801

Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.

Journal: Chemical research in toxicology20050601

Title: Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.

Journal: Cell research20050301

Title: Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.

Journal: Clinical and experimental immunology20041101

Title: Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.

Journal: Steroids20040901

Title: Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.

Journal: Journal of reproductive immunology20040401

Title: Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells.

Journal: Biochimica et biophysica acta20040210

Title: Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.

Journal: Human immunology20040201

Title: Comparative effects of L-tryptophan and 1-methyl-tryptophan on immunoregulation induced by sperm, human pre-implantation embryo and trophoblast supernatants.

Journal: American journal of reproductive immunology (New York, N.Y. : 1989)20031001

Title: Interferon-gamma independent oxidation of melatonin by macrophages.

Journal: Journal of pineal research20030101

Title: Tryptophan pyrrole ring cleavage enzymes in placenta.

Journal: Advances in experimental medicine and biology20030101

Title: Instruction of translating ribosome by nascent peptide.

Journal: Science (New York, N.Y.)20020913

Title: Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Journal: Science (New York, N.Y.)20020913

Title: FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses.

Journal: Journal of immunology (Baltimore, Md. : 1950)20020815

Title: Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.

Journal: Journal of neuroimmunology20020801

Title: Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.

Journal: The Journal of physiology20010815

Title: Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles.

Journal: The Journal of physiology20010301

Title: The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants.

Journal: The Journal of physiology20010301

Title: Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts.

Journal: Transplantation proceedings20010101

Title: Huang GL, et, al. PEG-Poly(1-Methyl-l-Tryptophan)-Based Polymeric Micelles as Enzymatically Activated Inhibitors of Indoleamine 2,3-Dioxygenase. Nanomaterials (Basel). 2019 May 9;9(5):719.

Title: Liu X, et, al. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells. Int J Cancer. 2018 Sep 15;143(6):1516-1529.

Building Blocks More >
5418-63-3
5418-63-3
1,2,3,3-Tetramethyl-3h-indolium iodide
AA0032H5 | MFCD09801052
7323-63-9
7323-63-9
1,4-Di-tert-butyl-2,5-dimethoxybenzene
AA0032KB | MFCD00026281
460-00-4
460-00-4
4-Bromofluorobenzene
AA0032N3 | MFCD00000342
832114-09-7
832114-09-7
2-(4-Methylpiperazino)pyridine-4-boronic acid pinacol ester
AA0032Q6 | MFCD05864305
498-17-9
498-17-9
2,2'-(Ethane-1,2-diylbis(azanediyl))dibutanoic acid
AA0032TB | MFCD00083323
773-01-3
773-01-3
2,4,6-Trimethylpyrylium tetrafluoroborate
AA0032VW | MFCD00032098
69385-30-4
69385-30-4
2,6-Difluorobenzylamine
AA0032YU | MFCD00010144
7752-82-1
7752-82-1
2-Amino-5-bromopyrimidine
AA00330U | MFCD00012341
69695-61-0
69695-61-0
2-Chloro-4-(trifluoromethoxy)aniline
AA00334V | MFCD01631704
4584-49-0
4584-49-0
2-Dimethylaminoisopropyl chloride hydrochloride
AA00337K | MFCD00012534
Submit
© 2017 AA BLOCKS, INC. All rights reserved.